UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 339

Sortiert nach

Emerging agents and regimens for hepatocellular carcinoma

Journal of hematology and oncology, 2019-10, Vol.12 (1), p.110-10, Article 110

2019

Volltextzugriff (PDF)

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview

Frontiers in oncology, 2021-11, Vol.11, p.772195-772195

2021

Volltextzugriff (PDF)

Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

Nature communications, 2021-07, Vol.12 (1), p.1-14, Article 4091

2021

Volltextzugriff (PDF)

Targeting angiogenesis for liver cancer: Past, present, and future

Genes & diseases, 2020-09, Vol.7 (3), p.328-335

2020

Volltextzugriff (PDF)

Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.1066-1075.e1

2013

Volltextzugriff (PDF)

Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects

Clinical cancer research, 2010-07, Vol.16 (13), p.3420-3430

2010

Volltextzugriff (PDF)

Lymphoid‐specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression

Cancer science, 2019-07, Vol.110 (7), p.2133-2144

2019

Volltextzugriff (PDF)

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

Journal of hematology and oncology, 2018-01, Vol.11 (1), p.12-12, Article 12

2018

Volltextzugriff (PDF)

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Journal of clinical oncology, 2008-06, Vol.26 (16), p.2707-2716

2008

Volltextzugriff (PDF)

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects

Genes & diseases, 2020-09, Vol.7 (3), p.359-369

2020

Volltextzugriff (PDF)

An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large‐Scale, Multicenter Study

The oncologist (Dayton, Ohio), 2019-12, Vol.24 (12), p.e1476-e1488

2019

Volltextzugriff (PDF)

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

Liver cancer (Basel ), 2021-07, Vol.10 (4), p.320-329

2021

Volltextzugriff (PDF)

Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study

Hepatology research, 2022-11, Vol.52 (11), p.947-956

2022

Volltextzugriff (PDF)

Sorafenib Down-regulates Expression of HTATIP2 to Promote Invasiveness and Metastasis of Orthotopic Hepatocellular Carcinoma Tumors in Mice

Gastroenterology (New York, N.Y. 1943), 2012-12, Vol.143 (6), p.1641-1649.e5

2012

Volltextzugriff (PDF)

Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection

Liver international, 2014-07, Vol.34 (6), p.953-960

2014

Volltextzugriff (PDF)

Cross talk between oxidative stress and hypoxia via thioredoxin and HIF‐2α drives metastasis of hepatocellular carcinoma

The FASEB journal, 2020-04, Vol.34 (4), p.5892-5905

2020

Volltextzugriff (PDF)

miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

The Journal of experimental medicine, 2013-04, Vol.210 (4), p.789-803

2013

Volltextzugriff (PDF)

MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression

Carcinogenesis (New York), 2013-09, Vol.34 (9), p.2071-2079

2013

Volltextzugriff (PDF)

MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma

PloS one, 2013-10, Vol.8 (10), p.e77957

2013

Volltextzugriff (PDF)

Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells

Clinical cancer research, 2009-08, Vol.15 (15), p.4838-4846

2009

Volltextzugriff (PDF)

Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy

European journal of surgical oncology, 2021-03, Vol.47 (3), p.681-689

2021

Volltextzugriff (PDF)

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

Therapeutic Advances in Medical Oncology, 2021, Vol.13, p.175883592110311-17588359211031141

2021

Volltextzugriff (PDF)

Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: A comparison with liver pathological results

Journal of gastroenterology and hepatology, 2014-04, Vol.29 (4), p.814-819

2014

Volltextzugriff (PDF)

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

BMC cancer, 2017-01, Vol.17 (1), p.58, Article 58

2017

Volltextzugriff (PDF)

Risk Factors, Prognosis, and Management of Early and Late Intrahepatic Recurrence After Resection of Primary Clear Cell Carcinoma of the Liver

Annals of surgical oncology, 2011-07, Vol.18 (7), p.1955-1963

2011

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(314)

Publikationsform

Sprache

Englisch
(310)
Japanisch
(39)
Chinesisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(181)
Humans
(150)
Hepatocellular Carcinoma
(112)
Male
(111)
Oncology
(105)
Female
(76)
Middle Aged
(75)
Liver Neoplasms - Pathology
(72)
Tumors
(70)
Carcinoma, Hepatocellular - Pathology
(66)
Liver Cancer
(66)
Animals
(54)
Prognosis
(52)
Adult
(50)
Aged
(47)
Mice
(45)
Cell Line, Tumor
(44)
Carcinoma, Hepatocellular - Metabolism
(43)
Liver Neoplasms - Metabolism
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Emerging agents and regimens for hepatocellular carcinoma

Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview

Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma

Targeting angiogenesis for liver cancer: Past, present, and future

Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes

Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects

Lymphoid‐specific helicase promotes the growth and invasion of hepatocellular carcinoma by transcriptional regulation of centromere protein F expression

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects

An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large‐Scale, Multicenter Study

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

Hazard rate for postoperative recurrence in patients with hepatocellular carcinoma at Barcelona Clinic Liver Cancer stage 0 or A1: A multicenter observational study

Sorafenib Down-regulates Expression of HTATIP2 to Promote Invasiveness and Metastasis of Orthotopic Hepatocellular Carcinoma Tumors in Mice

Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection

Cross talk between oxidative stress and hypoxia via thioredoxin and HIF‐2α drives metastasis of hepatocellular carcinoma

miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma

MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression

MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma

Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells

Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: A comparison with liver pathological results

Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B

Risk Factors, Prognosis, and Management of Early and Late Intrahepatic Recurrence After Resection of Primary Clear Cell Carcinoma of the Liver

Suchergebnisse filtern